Key result
Clinical diagnosis on admission misses 26% of acute MIs, contributing to thrombolytic therapy underuse.
Why the study?
A significant proportion of patients with acute myocardial infarction had their diagnosis missed on admission, leading to underuse of thrombolytic therapy and coronary care unit admission.
Population
Patients with a final diagnosis of acute myocardial infarction admitted to a district general hospital
Comparison
Correct diagnosis vs missed diagnosis on admission
Design
Observational audit with consultant diagnostic testing
Authors
Loading...
Missed MI diagnoses on admission may contribute to thrombolysis underuse; leaves open whether early biomarkers improve accuracy.
Observational
No
A significant proportion of acute MI diagnoses are missed on admission based on history and ECG alone, leading to underuse of thrombolytic therapy and highlighting the need for emergency biomarker testing.
Wong et al. (1994) conducted an observational in Acute myocardial infarction. Clinical diagnosis on admission was evaluated on Missed diagnosis of acute myocardial infarction on admission. Clinical diagnosis on admission missed 26% of acute myocardial infarctions, contributing to 51% of all patients not receiving thrombolytic therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: